Blog
Insights on AI, bioinformatics, and the future of life science research.
Every use case here is an analysis that was actually run on Ploid. Open one to see the question, the plan the agent chose and the result it produced.

October 29, 2026Partnerships
Breeding crops for a changing climate, with the scientist in charge
Ploid AI and MAS Seeds are working together to bring agentic AI bioinformatics into plant breeding, putting data analysis in the hands of MAS Seeds’ own scientists.
Ploid· Founding Team

pharmaceuticalOctober 21, 2026Use cases
Hen egg-white lysozyme: epitope mapping and antibody binder retrieval
Integrated structural analysis of 88 antibody-antigen complexes (24 distinct antibodies) on hen egg-white lysozyme (HEWL), yielding a per-residue immunodominance map and five epitope patches. Shows that CDR-loop geometry alone predicts epitope site (within- vs between-group overlap 0.954 vs 0.257) and delivers a retrieval method that recovers same-site antibodies at the top of the ranking (MRR 0.93 to 1.00).

October 14, 2026Partnerships
La Canastita and Ploid AI: putting genetic data at the heart of plant breeding
Ploid AI is working with La Canastita’s genetics teams at Berryum Varieties and Remo Varieties to bring genomic analysis into their breeding programs. What we are doing together, and the results we are seeing.
Ploid· Founding Team

September 15, 2026Company
What our ISO certifications mean for your data
Ploid AI is certified against ISO/IEC 27001, ISO 42001 and ISO 9001 by OCA Global. What each standard covers, why we did the work, and what it means for the security of the data you trust us with.
Ploid· Founding Team

pharmaceuticalUse cases
Ovarian carcinoma microenvironment: spatial immune exclusion mapping
Integrated spatial transcriptomic analysis of 407,124 cells from an ovarian carcinoma FFPE section, revealing an 18-fold vascular deficit and a stroma-restricted CD8 phenotype.

pharmaceuticalUse cases
Melanoma MAPK inhibitor response: multi-omic biomarker discovery
Integrated genomic, transcriptomic, and drug-sensitivity analysis of 122 GDSC melanoma cell lines, revealing BRAF V600 as a genomic biomarker of BRAF inhibitor sensitivity and a novel AXL/WNT5A/EGFR signature predicting MEK inhibitor resistance, supporting the rationale for BRAF+MEK combination therapy.

pharmaceuticalUse cases
Multi-omics integration: RNA-Seq, Methylation and ChIP-Seq
Integrated RNA-seq, spike-in ChIP-seq, and EPIC methylation array analysis of EZH2/DNMT inhibition in multiple myeloma (INA-6), revealing genome-wide H3K27me3 loss and its convergence with DNA methylation on oncogenic programs, supporting combination epigenetic therapy.

researchUse cases
Human paleofeces metagenomics
Shotgun metagenomic analysis of two human paleofeces samples using Kraken2 and Kaiju classifiers, revealing high inter-individual microbial dissimilarity, contrasting diversity profiles, and evidence of unsampled rare taxa beyond current sequencing depth.

agricultureUse cases
Blueberry fruit ripening RNA-Seq analysis
Transcriptomic reanalysis of ethylene-mediated fruit ripening in blueberry, integrating WGCNA, transcription factor network inference, and factorial interaction modeling to uncover the regulatory architecture of ripening.

pharmaceuticalUse cases
Spatial transcriptomics of human breast cancer
SOPA-based spatial transcriptomics analysis of Xenium human breast cancer FFPE tissue, mapping tumor microenvironment cell types, myoepithelial markers, fibroblast heterogeneity, and immune clusters using a 280-gene biomarker panel.

pharmaceuticalUse cases
Single-cell transcriptomic analysis of human PBMCs
Multi-layered scRNA-seq analysis of 10,000 human PBMCs identifying cell-type specific regulatory networks, druggable targets, and intercellular communication axes across seven immune cell populations.

agricultureUse cases
Blackberry thornlessness GWAS & functional annotation
Genome-wide association study in tetraploid blackberry identifying a WOX homeodomain transcription factor as the key regulator of prickle presence using GWASpoly and EggNOG functional annotation.
April 16, 2026Research
Ploid AI on BixBench: benchmarking our agent against the field
We evaluated Ploid AI on BixBench, the most realistic benchmark for bioinformatics agents. Here are our results across 20 bioinformatics domains, compared to leading general-purpose and domain-specific agents.
Ploid· Founding Team